| 000 | 03978nam a22003975i 4500 | ||
|---|---|---|---|
| 999 |
_c9973 _d9973 |
||
| 001 | 9973 | ||
| 003 | DE-He213 | ||
| 005 | 20210601040351.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 171013s2018 it | s |||| 0|eng d | ||
| 020 | _a9788847039551 | ||
| 024 | 7 |
_a10.1007/978-88-470-3955-1 _2doi |
|
| 040 |
_aES-MaUEC _bspa _dES-MaUEC |
||
| 050 | 4 |
_aRC280 _b.A236 2018 EB |
|
| 245 | 0 | 0 |
_aAbdominal Neuroendocrine Tumors _cedited by Massimo Carlini |
| 264 | 1 |
_aMilano _bSpringer Milan : _bImprint: Springer _c2018. |
|
| 300 | _a1 recurso en línea (200 páginas, 20 ilustraciones, 10 ilustraciones a color) | ||
| 336 |
_2rdacontent _aTexto (visual) _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_atext file _bPDF |
||
| 490 | 0 |
_aUpdates in Surgery _x2280-9848 |
|
| 490 | 0 | _aMedicine (Springer-11650) | |
| 505 | 0 | _aForeword -- Preface -- 1 Anatomophysiology of the neuroendocrine system: Embryology, Anatomy – Histology – Citology, Physiology -- 2 Epidemiology: Risk factors -- 3 Classification: WHO (grading), site -- 4 Pathology: Anatomic pathology, Immunohistochemistry. – 5 Molecular biology: Molecular pathways, Oncogenes, Suppressor genes -- 6 Clinical presentations: Non functioning NETs -- 7 Clinical presentations: Hormone releasing NETs (Carcinoid syndrome, Insulinoma, Glucagonoma, VIPoma, Somatostatinoma, Others, GRFoma -- 8 MEN 1, MEN 2am, MEN 2b, and Others (TSC, VHL, NF1) -- 9 Diagnosis: (Serum biomarkers, Endoscopy, Imaging (US, CT Scan, MRI, Angiography, Scintigraphy, PET) -- 10 Staging: TNM -- 11 Surgical treatment: Gastric NETs, Duodenum NETs, Jejuno-ileal NETs, Colorectal NETs, Pancreatic NETs (Head, Body-tail), Adrenal NETs -- 12 Non surgical treatments: Chemotherapy, Hormonal syndrome treatment, Targeted therapies, IFN -- 13 Metastatic disease: Liver metastases (Surgery, RF ablation and cryoablation, Arterial chemoembolization) -- 14 Systemic therapy (Somatostatina analogs, Alpha IFN, Cytotoxic chemotherapy, Peptide receptor radiotherapy, VEGF inhibitors, mTOR inhibitors -- 15 Flow-charts. | |
| 520 | 3 | _aThis book aims to equip readers with a better understanding of neuroendocrine tumors of the abdomen and explains how to manage them optimally by making use of novel therapeutic options that represent major advances on previous treatments. The most recent advances in epidemiology, genetics, molecular biology, biomarkers, pathology, diagnostics, clinical assessment, medical therapy, and surgical treatment are presented. The information and data provided will stimulate readers to develop their personal opinions on significant issues and assist in decision making in individual patients during routine clinical practice. The book features a multidisciplinary approach and is designed to meet the needs of all physicians seeking comprehensive guidance from experts on the management of patients with neuroendocrine tumors. It will also be of value for researchers wishing to acquaint themselves with the state of the art in the field and emerging research avenues. Abdominal Neuroendocrine Tumors is published in Springer’s highly successful Updates in Surgery series, which now comprises more than 20 titles. | |
| 650 | 7 |
_aGlándulas endocrinas _9302253 _2embne _xTumores |
|
| 700 | 1 |
_aCarlini, Massimo _eeditor literario _0http://id.loc.gov/authorities/names/n2018021699 _0http://viaf.org/viaf/29867635 |
|
| 710 | 2 |
_aSpringerLink (Online service) _0http://id.loc.gov/authorities/names/no2005046756 _0http://viaf.org/viaf/148105729 _9106996 |
|
| 776 | 0 | 8 |
_iEdición impresa: _z9788847039711 |
| 776 | 0 | 8 |
_iEdición impresa: _z9788847039544 |
| 776 | 0 | 8 |
_iEdición impresa: _z9788847039568 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-88-470-3955-1 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia) |
| 942 |
_2lcc _cLE |
||
| 998 | _db | ||